Erratum to "Patient and Provider Attitudes Toward Patient-Facing Kidney Organ Offer Reporting" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1122-1130].
「『Patient and Provider Attitudes Toward Patient-Facing Kidney Organ Offer Reporting』一文之勘誤啟事」
(原文刊載於《Kidney International Reports》2025年4月,第10卷第4期,頁1122-1130)
Kidney Int Rep 2025-07-18
Erratum to "Discordant Results Between Creatinine- and Cystatin C-based Equations for Estimating GFR" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1248-1259].
「『以肌酸酐與Cystatin C為基礎的GFR估算公式結果不一致』一文之勘誤啟事」
Kidney Int Rep 2025-07-18
Erratum to "Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1063-1075].
「關於『Dapagliflozin 對接受 Tolvaptan 治療之 ADPKD 患者影響的開放標籤、隨機、對照、交叉試驗』一文的更正啟事」
Kidney Int Rep 2025-07-18
Urinary Clusterin is a Biomarker of Renal Epithelial Senescence and Predicts Human Kidney Disease Progression.
尿液 Clusterin 為腎臟上皮細胞衰老的生物標誌,並可預測人類腎臟疾病進展
Kidney Int Rep 2025-07-18
Erratum to "Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1283-1287].
「更正啟事:使用 International IgA Nephropathy Prediction Tool 以優化臨床試驗受試者選擇」
Kidney Int Rep 2025-07-18
Corrigendum to "Lower Parathyroid Hormone Levels are Associated With Reduced Fracture Risk in Japanese Patients on Hemodialysis" [<i>Kidney International Reports</i> Volume 9, Issue 10, October 2024, Pages 2956-2969].
「更正啟事:『日本血液透析患者中較低的副甲狀腺素(Parathyroid Hormone)水準與骨折風險降低相關』[Kidney International Reports 第9卷第10期,2024年10月,頁2956-2969]」
Kidney Int Rep 2025-07-18